Extending Platelet Storage, Enhancing Patient Care

Preservation Bio is pioneering advancements in transfusion medicine, developing groundbreaking platelet preservation technology that addresses critical blood supply challenges.

About Us

Preservation Bio is tackling the global platelet shortage by extending platelet storage to 14 days with innovative ex vivo additives. Backed by leading research from the University of Cincinnati and Cincinnati Children’s Hospital, we are revolutionizing transfusion medicine.

Our Science

Explore how our technology prevents cold storage lesions and preserves platelet functionality, setting a new standard in transfusion medicine.

Investing in the Future of Transfusion Medicine

A subsidiary of Orange Grove Bio and backed by a $2.05 million SBIR Phase II grant, Preservation Bio is advancing a groundbreaking solution to extend platelet storage and improve transfusion outcomes. With our lead program approaching clinical trials, we are poised to address critical challenges in healthcare. Join us in transforming transfusion medicine and improving patient care worldwide.

"Extending platelet shelf life while maintaining functionality and safety is a critical challenge in transfusion medicine. To help address this challenge, we are pleased to support Preservation Bio’s innovative platelet preservation technology. Through our partnership, we aim to make a transformative impact on patient care and the platelet supply."

Dr. Ralph R. Vassallo, M.D.
Executive Vice President, Chief Medical & Scientific Officer, Vitalant

"This groundbreaking advancement in platelet storage technology is set to revolutionize care for cancer and trauma patients."

Dr. Pampee Young
Chief Medical Officer of Biomedical Services, American Red Cross

Ready to Connect?

We’re here to answer your questions and collaborate on groundbreaking research.